NYLI U.S. Large Cap R&D Leaders ETF LRND

Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis LRND

Will LRND outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin IQ US Large Cap R&D Leaders ETF's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LRND

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 49.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amazon.com Inc

8.46 635,607
Consumer Cyclical

Alphabet Inc Class A

7.90 593,802
Communication Services

Meta Platforms Inc Class A

6.79 509,920
Communication Services

Apple Inc

6.41 481,887
Technology

Microsoft Corp

5.21 391,629
Technology

Merck & Co Inc

4.23 318,009
Healthcare

Johnson & Johnson

3.19 239,987
Healthcare

Intel Corp

2.42 181,816
Technology

Bristol-Myers Squibb Co

2.21 166,248
Healthcare

Pfizer Inc

2.13 159,770
Healthcare

Sponsor Center